跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
臺北醫學大學器官移植研究中心
臺北醫學大學
概覽
指紋
網路
專家檔案
(20)
專案
(4)
研究成果
(509)
指紋
查看啟用 臺北醫學大學器官移植研究中心 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Abdominal Aortic Aneurysm
18%
Acute Kidney Injury
16%
Adverse Event
14%
Aortic Dissection
25%
Apoplexy
14%
Appendectomy
11%
Arrhythmogenesis
19%
Autophagy
15%
Biopsy
16%
Breast Cancer
74%
Cancer Cell
48%
Cancer Growth
22%
Cancer Stem Cell
20%
Carcinoma Cell
22%
Cardiovascular Disease
19%
Cardiovascular System
14%
Case-Control Study
14%
Cell Migration
14%
Chemoradiotherapy
29%
Cholangiocarcinoma
15%
Chronic Kidney Disease
95%
Cisplatin
15%
Clinical Stage
14%
Cohort Analysis
83%
Colorectal Cancer
15%
Compression Fracture
14%
Computer Assisted Tomography
10%
Cytoreductive Surgery
11%
Diabetes
16%
Diabetes Mellitus
12%
Dicer
18%
Disease
42%
Disease Free Survival
10%
Distant Metastasis
12%
down Regulation
10%
Dry Eye
13%
Elderly Patient
15%
End Stage Renal Disease
24%
Endovascular Aneurysm Repair
23%
Epidermal Growth Factor Receptor
17%
Esophageal Squamous Cell Carcinoma
22%
Eye Disease
13%
Hazard Ratio
39%
Health Care Cost
14%
Heart Surgery
11%
Hemodialysis
12%
Hepatectomy
30%
Hepatocellular Carcinoma
43%
Hyperthermic Intraperitoneal Chemotherapy
15%
In Vitro
24%
Incision
15%
Influenza Vaccination
15%
Injury
22%
Intensity Modulated Radiation Therapy
12%
Kidney Function
25%
Kidney Graft
19%
Kidney Transplantation
12%
Liver Transplantation
12%
Lung Adenocarcinoma
10%
Lung Cancer
29%
Macrophage
20%
Magnetic Resonance Imaging
12%
Malignant Neoplasm
34%
Meta-Analysis
49%
Metastatic Carcinoma
38%
microRNA
11%
Mortality Rate
14%
Neoplasm
64%
Nephropathy
16%
Non Small Cell Lung Cancer
38%
Observational Study
10%
Odds Ratio
17%
Operation Duration
17%
Overall Survival
22%
Oxidative Stress
11%
Percutaneous Vertebroplasty
18%
Programmed Cell Death
15%
Proportional Hazards Model
22%
Prostate Cancer
15%
Quality of Life
15%
Radiation Therapy
22%
Randomized Controlled Trial
25%
Reactive Oxygen Species
10%
Rectum Cancer
15%
Recurrent Disease
16%
Sepsis
12%
Signal Transduction
16%
Spine Surgery
11%
Surgeon
10%
Surgery
31%
Survival Rate
11%
Survivin
11%
Symptom
24%
Synapsin I
11%
Systematic Review
38%
Transitional Cell Carcinoma
11%
Treatment Response
15%
Triple Negative Breast Cancer
11%
Tumor Progression
10%
Upregulation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
15%
Acute Kidney Failure
11%
Adverse Event
29%
All Cause Mortality
9%
Androgen
9%
Angiotensin Receptor Antagonist
8%
Anticoagulant Agent
8%
Aortic Dissection
11%
Arrhythmogenesis
15%
Biological Marker
14%
Bladder Cancer
8%
Breast Cancer
57%
Cancer Growth
28%
Carbon Monoxide Poisoning
11%
Carcinogenicity
12%
Cardiovascular Disease
14%
Case-Control Study
9%
Castration Resistant Prostate Cancer
15%
Catenin
16%
Cell Viability
8%
Chemoradiation Therapy
16%
Chemotherapy
18%
Chronic Kidney Failure
99%
Cisplatin
22%
Cohort Study
50%
Colorectal Cancer
23%
Combination Therapy
16%
Comorbidity
14%
Compression Fracture
12%
Creatinine
9%
Cytokine
9%
Cytotoxicity
14%
Deterioration
18%
Diabetes Mellitus
12%
Disease
34%
Disease Exacerbation
13%
Diterpenoid
11%
Docetaxel
8%
Drug Resistance
18%
Dry Eye
13%
End Stage Renal Disease
19%
Epidermal Growth Factor Receptor
35%
Esophageal Squamous Cell Carcinoma
15%
Eye Disease
11%
Fibrosis
8%
Fluorouracil
8%
Fucoidan
8%
Glucose Regulated Protein 78
11%
Heart Atrium Remodeling
8%
Hedgehog
10%
Hematoma
9%
Hemodialysis
18%
Heparin
11%
Histone Deacetylase
11%
Hydrogen Peroxide
9%
Immunogenicity
19%
Inflammation
38%
Injury
14%
Janus Kinase
7%
Kidney Disease
10%
Kidney Injury
11%
Liver Cell Carcinoma
58%
Lung Cancer
29%
Malignant Neoplasm
87%
Metastasis
21%
microRNA
16%
Mitogen Activated Protein Kinase 3
8%
Monotherapy
9%
Mortality Rate
10%
Mouse
30%
Mouse Model
8%
Neoplasm
52%
Nicotinic Receptor
20%
Non Insulin Dependent Diabetes Mellitus
10%
Non Small Cell Lung Cancer
34%
Observational Study
9%
Overall Survival
14%
Oxaliplatin
8%
Paclitaxel
15%
Parathyroid Hormone
8%
Peritonitis
8%
Placebo
19%
Prevalence
7%
Prostate Cancer
18%
Randomized Controlled Trial
37%
Reactive Oxygen Metabolite
22%
Recurrent Disease
12%
Replacement Therapy
8%
Retrospective Study
10%
SARS Coronavirus
11%
Sodium Ion
9%
Stomach Cancer
19%
Survivin
16%
Symptom
18%
Synapsin I
11%
Thrombosis
11%
Tumor Growth
11%
Vaccination Policy
18%
Vismodegib
11%
Western Blot
12%
Biochemistry, Genetics and Molecular Biology
Advanced Glycation End-Product
5%
Allele
5%
Antibody Response
7%
Anticancer
9%
Atrial Fibrillation
5%
Autophagy
15%
Binding Protein
6%
Body Mass
5%
Bone Development
5%
Cancer Cell
100%
Cancer Stem Cell
25%
Carcinogenesis
12%
Catenin
16%
CD44
6%
Cell Cycle
7%
Cell Growth
10%
Cell Migration
21%
Cell Proliferation
15%
Cell Viability
7%
Cisplatin
13%
Cohort Study
19%
Colon
16%
Comorbidity
7%
Computer Model
8%
Cytokine
8%
Dendritic Cell
6%
Dicer
30%
down Regulation
18%
Drug Resistance
19%
Eicosanoid Receptor
8%
Endothelin
7%
Epidermal Growth Factor Receptor
17%
Ferroptosis
11%
Fibroblast
14%
Galectin-3
7%
Gefitinib
7%
Gemcitabine
12%
Gemcitabine
7%
Gene Expression
8%
Gene Polymorphism
8%
Genetic Divergence
10%
Genetics
7%
Genome-Wide Association Study
7%
Genotyping
12%
Glucose Blood Level
6%
Glucose-Regulated Protein
22%
Glutamine
5%
Heat Shock Protein
8%
Hemodialysis
15%
Histone Acetyltransferase
5%
Histone Deacetylase
6%
Histone Deacetylases Inhibitor
5%
Immunogenicity
5%
Kidney Function
23%
Kinase
6%
Ligase
11%
Lipopolysaccharide
6%
Macrophage
8%
Maturation
6%
Medline
7%
Mesenchymal-Epithelial Transition
16%
Messenger RNA
19%
Metabolic Pathway
15%
Methylation
26%
MicroRNA
24%
Mortality Rate
7%
Mouse
18%
MTT Assay
7%
Nicotinic Acetylcholine Receptor
7%
Nuclear Factor I
7%
Overall Survival
13%
Oxidative Stress
7%
P53
7%
Parathyroid Hormone
5%
Phosphotransferase
6%
Platelet-Rich Plasma
7%
Population
7%
Prevalence
8%
Promoter Region
9%
Protein Expression
6%
Real-Time Polymerase Chain Reaction
5%
Retrospective Study
5%
Signal Transduction
19%
Single-Nucleotide Polymorphism
16%
Small Interfering RNA
7%
Sorafenib
9%
Stem Cell
23%
Survivin
16%
Synapsin I
13%
Thrombomodulin
11%
Transcription Initiation
5%
Tumor Progression
14%
Tumor Suppressor Protein
6%
Tumor-Associated Macrophage
7%
TUNEL Assay
5%
Ubiquitin-Conjugating Enzyme
8%
Upregulation
19%
Vascular Endothelial Growth Factor
9%
Western Blot
5%
Wnt Signaling Pathway
6%